Curanex Pharmaceuticals Inc Common Stock Net Asset Momentum
Curanex Pharmaceuticals Inc Common Stock net asset momentum. Curanex Pharmaceuticals Inc Common Stock (CURX) recorded a net asset momentum of 737.7% as of December 2024, with net assets of $503.36K USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Check Curanex Pharmaceuticals Inc Common Stock total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Curanex Pharmaceuticals Inc Common Stock (2022–2024)
Net asset momentum of Curanex Pharmaceuticals Inc Common Stock from 2022 to 2024. This chart tracks Curanex Pharmaceuticals Inc Common Stock's year-over-year net asset growth across 3 annual reporting periods from 2022 to 2024. The most recent momentum reading is +737.7%, with net assets of $503.36K USD as of December 2024. See CURX net asset value for net asset value and shareholders' equity analysis.
Curanex Pharmaceuticals Inc Common Stock Net Asset Momentum by Year (2022–2024)
Curanex Pharmaceuticals Inc Common Stock net asset momentum by year from 2022 to 2024. The table below shows the complete annual net asset history for Curanex Pharmaceuticals Inc Common Stock from 2022 to 2024, covering 3 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see market cap of Curanex Pharmaceuticals Inc Common Stock.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | $503.36K | $517.93K | $14.57K | ▲ +737.7% |
| 2023 | $60.09K | $74.37K | $14.28K | ▲ +487.3% |
| 2022 | $10.23K | $10.23K | $0.00 | — |